University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...

India’s R&D needs faster, predictable approval timelines to boost investor confidence: Dr Jogin Desai: Our Bureau, Bengaluru Friday, April 17, 2026, 15:30 Hrs [IST] India’s re ...

Peer-reviewed study confirming strong predictive performance of patient-specific lung digital twins, validated against ...

Regulatory milestone supports broader adoption of C-mo's privacy-preserving technology in clinical research and medical practice Approval covers ...

C-mo Medical Solutions receives CE Mark for its novel AI-powered cough monitoring in patients: Lisbon, Portugal Saturday, April 18, 2026, 10:00 Hrs [IST] C-mo Medical Solutions, a ...

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...

A protein called PIEZO1, which is linked to mechanical stress, may play a key role in driving pulmonary fibrosis, a study ...

Ebenbuild GmbH, a Munich-based deep-tech healthcare company, today announced the publication of a peer-reviewed ...

Amazon has reportedly developed an artificial intelligence platform called Bio Discovery, designed to help drug researchers ...

A macrophage that has already fought off one infection does not return to a blank slate. It carries chemical scars, etched ...

Veracyte Inc. company and executive profile by Barron's. View the latest 12V company infomation and executive bios.

There seems to be a strong exposure-response relationship between nerandomilast and the preservation of FVC in patients with PPF and IPF.